AT&T and Pfizer Offer Juicy 6%+ Dividends, But Face Challenges

AT&T and Pfizer offer ultra-high dividend yields over 6% which should attract investors when interest rates fall.

AT&T trades at a discount compared to telecom industry average and has a sustainable high dividend yield.

Pfizer is trading at a bargain valuation compared to big pharma competitors and has an impressive 6.2% dividend yield.

AT&T is working on cost reductions to support its high dividend payouts and reduce debt.

Pfizer's stock price has dropped due to decreasing COVID product sales and patent expirations, but its pipeline has potential.